Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea

Current Medical Research and Opinion

Volumn 28, Issue 5, 2012, Pages 731-736

  Lund, Asger ^a   Knop, Filip K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adverse effects; Hypoglycaemia; Patient knowledge; Patient worry; Side effects; Sulphonylurea; Type 2 diabetes mellitus; Weight gain

Indexed keywords

GLUCOSE; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HUMAN; HYPOGLYCEMIA; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; RISK FACTOR; SIDE EFFECT; WEIGHT GAIN;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; QUESTIONNAIRES; SULFONYLUREA COMPOUNDS; WEIGHT GAIN;

EID: 84861109293     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.681639     Document Type: Article

References (24)

1. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-72 (Pubitemid 23318125)
2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53
4. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990;132:501-13 (Pubitemid 20285148)
5. Henquin JC. The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work? Diabetologia 1992;35:907-12
6. Currie CJ, Morgan CL, Poole CD, et al. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin 2006;22:1523-34 (Pubitemid 44297431)
7. Stargardt T, Gonder-Frederick L, Krobot KJ, et al. Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health Qual Life Outcomes 2009;7:91
8. Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989;12:203-8 (Pubitemid 19071489)
9. Miller CD, Phillips LS, Ziemer DC, et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161:1653-9 (Pubitemid 32681147)
10. Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008;10(Suppl 1):16-24
11. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14:750-6
12. Peyrot M, Skovlund SE, Landgraf R. Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study. Curr Med Res Opin 2009;25:1985-93
13. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9 (Pubitemid 29504045)
14. Anderson JW, Konz EC. Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 2001;9(Suppl 4):326S-334S
15. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-76
16. Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007;68:10-15 (Pubitemid 47126791)
17. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12 (Pubitemid 36929141)
18. Foley JE, Jordan J. Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience. Vasc Health Risk Manag 2010;6:541-8
19. Boøgelund M, Vilsboøll T, Faber J, et al. Patient preferences for diabetes management among people with type 2 diabetes in Denmark -a discrete choice experiment. Curr Med Res Opin 2011;27:2175-83
20. Skinner KM, Miller DR, Lincoln E, et al. Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambul Care Manage 2005;28:102-10 (Pubitemid 40478361)
21. Ng SP, Korda R, Clements M, et al. Validity of self-reported height and weight and derived body mass index in middle-aged and elderly individuals in Australia. Aust New Zeal J Publ Health 2011;35:557-63
22. Lin CJ, Deroo LA, Jacobs SR, et al. Accuracy and reliability of self-reported weight and height in the Sister Study. Public Health Nutrition 2011;9:1-11
23. Schioøtz M, Boøgelund M, Willaing I. Challenges using online surveys in a Danish population of people with type 2 diabetes. Chronic Illn 2012;8(1):56-63
24. Blonde L. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. Am J Med 2010;123:S12-18